期刊文献+

恶性血液肿瘤脊柱骨髓弥漫性浸润的动态对比增强MR灌注成像 被引量:2

Dynamic Contrast-enhanced MR Perfusion imaging of Diffuse Spinal Bone Marrow Infiltration in Patients with Hematological Malignancies
下载PDF
导出
摘要 目的评价动态对比增强MR灌注成像对恶性血液肿瘤脊柱骨髓弥漫性浸润性病变的诊断价值。资料与方法经骨髓组织活检确诊的恶性血液肿瘤26例和20例正常对照者行腰椎动态对比增强MR灌注成像检查。计算峰值增强百分率(Emax)、增强斜率(ES)和到达峰值时间(TTP)。结果脊柱骨髓弥漫性恶性浸润组与正常对照组间的Emax、ES和TTP均具有显著差异(P<0.01)。骨髓轻度浸润和中度浸润之间的Emax、ES和TTP均具有显著差异(P<0.05)。骨髓轻度浸润和重度浸润之间的Emax、ES和TTP均具有显著差异(P<0.01)。骨髓中度浸润和重度浸润之间的Emax、ES和TTP无显著差异(P>0.05)。Emax、ES和骨髓浸润程度之间具有正相关性(P<0.01),TTP和骨髓浸润程度之间具有负相关性(P<0.01)。结论动态对比增强MR灌注成像可以判断恶性血液肿瘤是否出现脊柱骨髓弥漫性浸润,灌注参数可以反映骨髓肿瘤细胞浸润程度。 Objective To evaluate the role of dynamic contrast - enhanced MR perfusion imaging in the diagnosis of diffuse spinal bone marrow infiltration in patients with hematological malignancies. Materials and Methods Dynamic contrast - enhanced MR perfusion imaging of the lumbar spine was performed in 26 patients with diffuse bone marrow infiltration by hematological malignancies confirmed by biopsy and 20 normal subjects. Peak enhancement percentage (Emax) , enhancement slope (ES) , and time to peak (TTP) were measured. Results There was a significant difference in Emax, ES, and TIP values between the spinal bone marrow infiltration group and normal control group (P 〈0.01 ). Emax, ES and TrP values were significantly different between the mild bone marrow infiltration group and the moderate bone marrow infiltration group ( P 〈 0.05 ). E ES and TrP values were also significantly different between the mild bone marrow infiltration group and the severe bone marrow infihration group (P 〈 0. 01 ). However, There was no significant difference in Emax, ES, and TTP values between the moderate bone marrow infiltration group and severe bone marrow infiltration group ( P 〉 0.05 ). There was a positive correlation between Emax and ES values and the degree of bone marrow infiltration (P 〈 0.01 ). A negative correlation was found between TIP values and the degree of bone marrow infiltration ( P 〈 0. 01 ). Conclusions Dynamic contrast - enhanced MR perfusion imaging of the spine could demonstrate diffuse bone marrow infiltration of hematological malignancies, and perfusion imaging parameters could reflect the degree of bone marrow infiltration.
出处 《临床放射学杂志》 CSCD 北大核心 2008年第3期372-376,共5页 Journal of Clinical Radiology
关键词 血液 肿瘤 骨髓 磁共振成像 Blood Neoplasm Bone marrow Magnetic resonance imaging
  • 相关文献

参考文献13

  • 1Stabler A, Baur A, Bartl R,et al. Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates. Am J Rocntgenol, 1996, 167:1029
  • 2Lecouvet FE, Vande Berg BC, Michaux L,et al. Stage Ⅲ multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging. Radiology, 1998, 209:653
  • 3Baur A, Stabler A, Bartl R,et al. MRI gadolinium enhancement of bone marrow : age-related changes in normals and in diffuse neoplastic infiltration. Skeletal Radiol, 1997, 26:414
  • 4Moehler TM, Hawighorst H, Neben K,et al. Bone marrow microcirculation analysis in multiple myeloma by contrast-enhanced dynamic magnetic resonance imaging. Int J Cancer, 2001,93:862
  • 5Rahmouni A, Montazel JL, Divine M,et al. Bone marrow with diffuse tumor infiltration in patients with lymphoproliferative diseases: dynamic gadolinium-enhanced MR imaging. Radiology, 2003,229: 710
  • 6Moulopoulos LA, Maris TG, Papanikolaou N,et al. Detection of malignant bone marrow involvement with dynamic contrast-enhanced magnetic resonance imaging. Ann Oncol, 2003, 14:152
  • 7Vande Berg BC, Lecouvet FE, Michaux L, et al. Magnetic resinance imaging of the bone marrow in hematological malignancies. Eur Radio, 1998, 8:1335
  • 8吴涛,胡豫.血管新生与多发性骨髓瘤[J].临床血液学杂志,2005,18(1):61-63. 被引量:4
  • 9张育,顾健,王敏,马莉,王晓铃,何斌,孙梅.白血病患者血管新生及相关因素研究[J].中华血液学杂志,2005,26(3):175-178. 被引量:7
  • 10童允洁,张敏,邹萍,郭荣,袁永辉.血管内皮生长因子反义寡核苷酸对裸鼠淋巴瘤血管生成的影响[J].癌症,2005,24(1):62-66. 被引量:2

二级参考文献43

  • 1张育,顾健,王敏,马莉,王晓铃,何斌,孙梅.白血病患者血管新生及相关因素研究[J].中华血液学杂志,2005,26(3):175-178. 被引量:7
  • 2Shi W, Siemann DW. Inhibition of renal cell carcinoma angiogenesis and growth by antisense oligonucleotides targeting vascular endothelial growth factor [J]. Br J Cancer, 2002, 87 (1):119-126.
  • 3Bellamy WT, Richter L, Frutiger Y, et al. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies [J ]. Cancer Res, 1999, 59 (3) :728-733.
  • 4Masood R, Cai J, Zheng T, et al. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma [J]. Proc Natl Acad Sci USA, 1997, 94 (3): 979-984.
  • 5Soker S, Gollamudi-Payne S, Fidder H, et al. Inhibition of vascular endothelial growth factor(VEGF)-induced endothelial cell proliferation by a peptide corresponding to the exon 7-encoded domain of VEGF165 [J]. J Biol Chem, 1997, 272(50) : 31582-31588.
  • 6Bosari S, Lee AK, Delellis RA, et al. Microvessel quantitation and prognosis in invasive breast carcinoma [J]. Hum Pathol, 1992, 23 (7):755-761.
  • 7Plate KH, Breier G, Weich HA, et al. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo [J]. Nature, 1992, 359 (6398):845-848.
  • 8Gasparini G, Toi M, Gion M, et al. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma [J]. J Nail Cancer Inst, 1997, 89 (2):139-147.
  • 9Shi W, Siemann DW. Inhibition of renal cell carcinoma angiogenesis and growth by antisense oligonucleotides targeting vascular endothelial growth factor [J]. Br J Cancer, 2002,87 (1):119-126.
  • 10Bellamy WT, Richter L, Frutiger Y, et al. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies [J]. Cancer Res, 1999, 59 (3):728-733.

共引文献22

同被引文献24

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部